LW was doing some general portfolio trimming (read dumping) earlier this year. It was across the board. This is worth $1b upon a successful Phase 3 and NDA with FDA. Very attractive risk v reward vs most biotechs which are many years away from actual commercialisation and have to raise $50m + to get there. Not long to wait now and I am encouraged now that the anecdotal feedback from trial (lav and lilac) echoes what was coming out during phase 2a and b. Just need to hope results are consistent with some of that caregiver feedback.
NEU Price at posting:
$1.46 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)